Imeik Technology Development Co.,Ltd. (SHE:300896)

Market Cap	27.55B -52.5%
Revenue (ttm)	2.37B -11.2%
Net Income	1.09B -32.7%
EPS	3.63 -32.8%
Shares Out	301.43M
PE Ratio	25.17
Forward PE	20.04
Dividend	1.60 (1.70%)
Ex-Dividend Date	Apr 29, 2026

Volume	2,747,470
Open	92.30
Previous Close	92.36
Day's Range	91.00 - 93.81
52-Week Range	83.36 - 202.88
Beta	0.62
Analysts	Buy
Price Target	135.07 (+53.56%)
Earnings Date	Aug 21, 2026

About SHE:300896

Imeik Technology Development Co.,Ltd. engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China. The company offers aesthetic medicine products, such as cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere; poly facial implant thread; medical sodium hyaluronate-hydroxypropyl methylcellulose gel; sodium hyaluronate composite solution for injection; modified sodium hyaluronate gel for injection; medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose gel; a...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2004
• Employees: 1,458
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300896

Financial Performance

In 2025, SHE:300896's revenue was 2.45 billion, a decrease of -18.94% compared to the previous year's 3.03 billion. Earnings were 1.29 billion, a decrease of -34.05%.

Analyst Summary

According to 12 analysts, the average rating for 300896 stock is "Buy." The 12-month stock price target is ¥135.07, which is an increase of 53.56% from the latest price.

Price Target

¥135.07

(53.56% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 24, 2026

Data Sources Report a data error